Harish Shantharam - May 22, 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Chief Financial Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Harish Shantharam
Stock symbol
CBAY
Transactions as of
May 22, 2023
Transactions value $
$0
Form type
4
Date filed
5/22/2023, 05:13 PM
Next filing
Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +360K $0.00 360K May 22, 2023 Common Stock 360K $8.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the underlying shares on May 22, 2024 and vests as to 1/48 of the underlying shares monthly thereafter.